Dr. Alexandru Corlateanu, MD, PhD - State University of Medicine and Pharmacy  - Associate Professor

Dr. Alexandru Corlateanu

MD, PhD

State University of Medicine and Pharmacy

Associate Professor

Chisinau | Moldova, Republic of

Main Specialties: Pulmonary Disease, Pulmonary Disease & Critical Care Medicine

ORCID logohttps://orcid.org/0000-0002-3278-436X

Dr. Alexandru Corlateanu, MD, PhD - State University of Medicine and Pharmacy  - Associate Professor

Dr. Alexandru Corlateanu

MD, PhD

Introduction

Dr. Corlateanu is the Associate Professor at Department of Respiratory medicine at State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Moldova. He is National Leader for Moldova at The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and member of the The Global Initiative for Asthma (GINA) Assembly for Moldova. Dr. Corlateanu also served as National Delegate of European Respiratory Society (ERS) for Moldova. He has written over 50 peer-reviewed articles and several book chapters. He is a reviewer for multiple reputed journals in the field of respiratory diseases and the Assistant Editor for Current Respiratory Medicine Reviews and the Associate Editor for COPD Research and Practice. Also he is a author of Respirtory Decade blog (http://respiratorydecade.blogspot.md/).

Primary Affiliation: State University of Medicine and Pharmacy - Chisinau , Moldova, Republic of

Specialties:

Education

Sep 1996 - Jun 2002
Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu
MD
Sep 1996 - Jun 2002
Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu
MD

Experience

Mar 2012
Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu
Associate Professor
Pulmonology and Allergology

Publications

42Publications

250Reads

495Profile Views

5PubMed Central Citations

Chronic Obstructive Pulmonary Disease and Stroke.

COPD 2018 Jun-Aug;15(4):405-413. Epub 2018 May 10.

d University General Hospital , Department of Thoracic Medicine, Stavrakia , Heraklion , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15412555.2018.1464551DOI Listing
May 2018
56 Reads

Predicting Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: The Impact of Age.

Respiration 2016 15;92(4):229-234. Epub 2016 Sep 15.

Department of Respiratory Medicine, State University of Medicine and Pharmacy 'Nicolae Testemitanu', Chisinau, Republic of Moldova.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/448625
Publisher Site
http://dx.doi.org/10.1159/000448625DOI Listing
September 2017
50 Reads
2.593 Impact Factor

Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.

Respir Investig 2016 Nov 8;54(6):387-396. Epub 2016 Aug 8.

University General Hospital, Department of Thoracic Medicine, Stavrakia, 71110 Heraklion, Crete, Greece. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resinv.2016.07.001DOI Listing
November 2016
95 Reads
2 Citations

Predictors of daytime sleepiness in patients with obstructive sleep apnea.

Pneumologia 2015 Oct-Dec;64(4):21-5

View Article

Download full-text PDF

Source
August 2016
9 Reads
3 Citations

From smoking to COPD--current approaches.

Pneumologia 2016 Jan-Mar;65(1):20-3

View Article

Download full-text PDF

Source
June 2016
19 Reads

[Cryptococcosis--a common fungal infection in immunosuppressed patient].

Pneumologia 2014 Jul-Sep;63(3):156, 159-63

View Article

Download full-text PDF

Source
January 2015
5 Reads

Overlap Syndrome in Respiratory Medicine: Asthma and COPD

J of Cardio-Thoracic Med. 2014; 2:109-112.

J of Cardio-Thoracic Med

Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic diseases in the general population. Both are characterized by similar mechanisms: airway inflammation, airway obstruction, and airway hyperresponsiveness. However, the distinction between the two obstructive diseases is not always clear. Multiple epidemiological studies demonstrate that in elderly people with obstructive airway disease, as many as half or more may have overlapping diagnoses of asthma and COPD. A COPD-Asthma overlap syndrome is defined as an airflow obstruction that is not completely reversible, accompanied by symptoms and signs of increased obstruction reversibility. For the clinical identification of overlap syndrome COPD-Asthma Spanish guidelines proposed six diagnostic criteria. The major criteria include very positive bronchodilator test [increase in forced expiratory volume in one second (FEV1) ≥15% and ≥400 ml], eosinophilia in sputum, and personal history of asthma. The minor criteria include high total IgE, personal history of atopy and positive bronchodilator test (increase in FEV1 ≥12% and ≥200 ml) on two or more occasions. The overlap syndrome COPD-Asthma is associated with enhanced response to inhaled corticosteroids due to the predominance of eosinophilic bronchial inflammation. The future clinical studies and multicenter clinical trials should lead to the investigation

View Article
January 2014
11 Reads

Top co-authors

Victor Botnaru
Victor Botnaru

Universitatea de Stat de Medicin? ?i Farmacie Nicolae Testemi?anu Clinica Medical? nr. 2. chesov.dumitru@gmail.com

6
Alexander G Mathioudakis
Alexander G Mathioudakis

University Hospital Aintree

3
Nikolaos Siafakas
Nikolaos Siafakas

Clinical Microbiology Laboratory

3
Alexandru Corlateanu
Alexandru Corlateanu

State University of Medicine and Pharmacy

2
Jana Skrickova
Jana Skrickova

Papageorgiou General Hospital

1
Doina Rusu
Doina Rusu

Universitatea de Stat de Medicin? ?i Farmacie Nicolae Testemi?anu Clinica Medical? nr. 2. chesov.dumitru@gmail.com

1